NFKB1 and COVID-19: Indeed, a synergy between NF-κB and STAT3 molecules based on pro-inflammatory cytokines (i.e., IL-6), which act as inflammation amplifier, was reported in several multiple inflammatory and autoimmune diseases [100] and postulated also in COVID-19 [101].